Bis-(2-amino-5-selenazoyl) ketone as a superoxide anion-scavenger

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 7, 2006, Pages 1404-1407

  Sekiguchi, Akihiro ^a   Nishina, Atsuyoshi ^a   Kimura, Hirokazu ^b   Fukumoto, Ryo Hei ^a   Kogami, Masakazu ^c   Ishihara, Hideharu ^c   Koketsu, Mamoru ^c  

^a Gunma Prefectural Industrial Technology Center   (Japan)

^b GUNMA PREFECTURAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^c GIFU UNIVERSITY   (Japan)

Author keywords

2 amino 1,3 selenazole; Heterocycle; Scavenging effect; Superoxide anion scavenging activities (SOSAs); Superoxide radical

Indexed keywords

2 AMINO 1,3 SELENAZOLE DERIVATIVE; 5 ACETYL 2 MORPHOLINO 1,3 SELENAZOLE; 5 ACETYL 2 PIPERIDINO 1,3 SELENAZOLE; 5 BENZOYL 2 DIMETHYLAMINO 1,3 SELENAZOLE; 5 BENZOYL 2 MORPHOLINO 1,3 SELENAZOLE; 5 BENZOYL 2 PIPERIDINO 1,3 SELENAZOLE; BIS (2 AMINO 5 SELENAZOYL) KETONE; BIS[2 DIMETHYLAMINO 5 (1,3 SELENAZOYL)] KETONE; BIS[2 MORPHOLINO 5 (1,3 SELENAZOYL)] KETONE; KETONE DERIVATIVE; SCAVENGER; SELENAZOLE DERIVATIVE; SUPEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CHEMOLUMINESCENCE; IN VITRO STUDY; SYNTHESIS;

FREE RADICAL SCAVENGERS; KETONES; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; ORGANOSELENIUM COMPOUNDS; SUPEROXIDE DISMUTASE; SUPEROXIDES; XANTHINE OXIDASE;

EID: 33745714085     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1404     Document Type: Article

References (18)

1. Hsu P. C., Guo Y. L., Toxicology, 180, 33-44 (2002).
2. Long J. F., Dutta P. K., Hogg B. D., Environ. Health Perspect., 105, 706-711 (1997).
3. Ramirez R., Carracedo J., Jimenez R., Canela A., Herrera E., Aljama P., Blasco M. A., J. Biol. Chem., 278, 836-842 (2003).
4. Fridovich I., Annu. Rev. Biochem., 64, 97-112 (1995).
5. Ricci J.-E., Gottlieb R. A., Green D. R., J. Cell. Biol., 160, 65-75 (2003).
6. Kimura H., Sawada T., Oshima S., Kozawa K., Ishioka T., Kato M., Curr. Drug Targets Imflamm. Allergy, 4, 489-495 (2005).
7. Kato M., Kimura H., Motegi Y., Tachibana A., Minakami H., Morikawa A., Kita H., J. Immunol., 169, 5252-5259 (2002).
8. Wendel A., Tiegs G., Biochem. Pharmacol., 35, 2115-2118 (1986).
9. Taino L., Fedeli D., Santroni A. M., Villarini M., Engman L., Falcioni G., Mutat. Res., 464, 269-277 (2000).
10. Jeong D. W., Kim T. S., Chung Y. W., Lee B. J., Kim I. Y., FEBS Lett., 517, 225-228 (2002).
11. Engman L., Hallberg A., J. Org. Chem., 54, 2964-2966 (1989).
12. Zhang M., Nomura A., Uchida Y., Iijima H., Sakamoto T., Iishii Y., Morishima Y., Mochizuki M., Masuyama K., Hirano K., Sekizawa K., Free Radical Biol. Med., 32, 454-464 (2002).
13. Nakamura Y., Feng Q., Kumagai T., Torikai K., Ohigashi H., Osawa T., Noguchi N., Niki E., Uchida K., J. Biol. Chem., 277, 2687-2694 (2002).
14. Takahashi H., Nishina A., Kimura H., Motoki K., Koketsu M., Ishihara H., Eur. J. Pharm. Sci., 23, 207-211 (2004).
15. Takahashi H., Nishina A., Fukumoto R., Kimura H., Koketsu M., Ishihara H., Life Sci., 76, 2185-2192 (2005).
16. Takahashi H., Nishina A., Fukumoto R., Kimura H., Koketsu M., Ishihara H., Eur. J. Pharm. Sci., 24, 291-295 (2005).
17. Koketsu M., Kogami M., Ando H., Ishihara H., Synthesis, 31-36 (2006).
18. Kimura H., Nakano M., FEBS Lett., 239, 347-350 (1988).